Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Z-VAD-FMK: Benchmark Irreversible Pan-Caspase Inhibitor for
2026-04-25
Z-VAD-FMK is a validated, cell-permeable, irreversible pan-caspase inhibitor used to dissect apoptosis and related pathways. Its selectivity for pro-caspase inhibition underpins its utility in cell death research. APExBIO’s formulation offers high purity and reproducible results for in vitro and in vivo studies.
-
Distinct Apoptotic Pathways in BMECs Triggered by Candida kr
2026-04-24
This study elucidates how the yeast and hypha phases of Candida krusei induce apoptosis in bovine mammary epithelial cells (BMECs) through separate signaling mechanisms. The findings clarify the molecular basis of mycotic mastitis and offer a foundation for targeted research into apoptosis modulation in epithelial and immune contexts.
-
Valemetostat (DS-3201): Precision Epigenetic Cancer Applicat
2026-04-24
Valemetostat (DS-3201) sets a new benchmark for selective, potent EZH2 inhibition, supporting advanced lymphoma research and epigenetic therapeutic development. Explore protocol-driven workflows, troubleshooting insights, and translational guidance—backed by recent breakthroughs and APExBIO’s validated supply chain.
-
Pterostilbene Enhances Mitophagy to Delay Dermal Fibroblast
2026-04-23
Zhou et al. (2025) reveal that pterostilbene mitigates human dermal fibroblast senescence by improving mitochondrial quality via enhanced mitophagy. These findings highlight mitochondrial quality control as a promising anti-aging target in skin research.
-
Annexin V-APC/7-AAD Apoptosis Kit: Precision Apoptosis Detec
2026-04-23
The Annexin V-APC/7-AAD Apoptosis Kit enables rapid, dual-parameter detection of apoptosis and necrosis in mammalian cells. As an advanced apoptosis detection kit, it combines phosphatidylserine binding with DNA-staining to distinguish cell death stages with high sensitivity. This article details its mechanism, benchmarks, and best practices for robust apoptosis and necrosis detection workflows.
-
SGI-1027 and Everolimus Synergy: Inducing Non-Apoptotic Cell
2026-04-22
This study uncovers a novel cytotoxic mechanism of the DNA methyltransferase inhibitor SGI-1027 in renal cell carcinoma, demonstrating its ability to induce methuosis and potentiate everolimus-mediated apoptosis and pyroptosis. The findings highlight the therapeutic promise of combining epigenetic modulation and mTOR inhibition for overcoming drug resistance in advanced renal cancer.
-
Cinoxacin In Vitro Antibacterial Profile: MICs, Spectrum, an
2026-04-22
This study by Lumish and Norden systematically profiles the in vitro antibacterial activity of Cinoxacin, a synthetic quinolone antibiotic, against a large set of Gram-negative clinical isolates. Its findings establish Cinoxacin’s MIC spectrum, bactericidal properties, and resistance potential, informing its relevance for urinary tract infection and resistance research.
-
Targeting Cdc42 to Mitigate Kidney Fibrosis: Key Advances an
2026-04-21
A recent study identifies Cdc42 as a pivotal regulator of kidney fibrosis, demonstrating that the natural diterpenoid daphnepedunin A suppresses fibrosis by inhibiting Cdc42-mediated GSK-3β/β-catenin signaling. This work substantiates Cdc42 as a promising therapeutic target and provides a mechanistic basis for advancing selective Cdc42 inhibitors in fibrotic disease research.
-
PBS Liposomes: Reliable Controls for Macrophage Depletion As
2026-04-21
This article explores the practical challenges of in vivo macrophage depletion studies and demonstrates how PBS Liposomes (SKU K2722) provide a robust, inert control for distinguishing clodronate-specific effects. By integrating scenario-driven Q&A, we highlight reproducibility, safety, and data integrity benefits for researchers employing PBS Liposomes.
-
2-APB: Precision Control of Calcium Signaling in Cell Models
2026-04-20
Harnessing 2-APB, a selective IP3 receptor antagonist from APExBIO, empowers researchers to dissect and modulate calcium-dependent processes such as autophagy, apoptosis, and oxidative stress injury. This guide delivers actionable workflows, troubleshooting insights, and advanced application tips for maximizing experimental clarity.
-
Thiothixene Stimulates Macrophage Efferocytosis via Arginase
2026-04-20
The referenced Sci Signal study reveals that thiothixene, a typical antipsychotic agent, enhances macrophage-mediated clearance of apoptotic and lipid-laden cells by upregulating Stra6L and Arginase 1. These mechanistic insights position thiothixene as a translational tool for immune modulation, with implications for disease states marked by defective efferocytosis.
-
G418 Sulfate (Geneticin): Precision Selection & Antiviral In
2026-04-19
G418 Sulfate (Geneticin) stands at the forefront of genetic engineering and antiviral research, uniquely enabling robust selection of neomycin-resistant cell lines and direct inhibition of pathogenic viruses like Dengue. This guide delivers actionable, evidence-based protocols, troubleshooting strategies, and insight into leveraging Geneticin’s dual functionality for next-generation biomedical workflows.
-
Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl
2026-04-18
This study demonstrates that certain p38α MAPK inhibitors not only suppress kinase activity but also accelerate dephosphorylation of the activation loop by phosphatases, introducing a dual-action paradigm. These findings provide structural and mechanistic insight into kinase-phosphatase interplay, with implications for the design of more selective and potent therapeutic inhibitors.
-
Z-WEHD-FMK: Advanced Insights into Caspase-Driven Pyroptosis
2026-04-17
Explore how Z-WEHD-FMK, a potent caspase inhibitor, enables high-resolution dissection of inflammatory cell death and microbial pathogenesis. This article reveals new assay strategies and mechanistic insights distinct from standard product reviews.
-
Bradykinin B2 Receptors and Peristaltic Reflex Modulation in
2026-04-16
This study provides the first systematic investigation of how bradykinin B2 receptors modulate the peristaltic reflex in the guinea pig ileum. By dissecting the pharmacological roles of B2 versus B1 receptors, the work clarifies the mechanistic basis for bradykinin-mediated inhibition of gastrointestinal motility, with implications for both gastrointestinal and cardiovascular research.